Evalobo, Bj Van Kyle T.
HRN: 06-58-43 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/11/2024
CEFTRIAXONE 1G (VIAL)
03/11/2024
03/18/2024
IV
2 Grams
Q24
PCAP; BA In AE
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes